Business Description
Keymed Biosciences Inc
ISIN : KYG5252B1023
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 3.56 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.28 | |||||
Debt-to-EBITDA | -1.14 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 6.11 | |||||
Beneish M-Score | 0.51 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 31 | |||||
3-Year EPS without NRI Growth Rate | 25.2 | |||||
3-Year FCF Growth Rate | -67.7 | |||||
Future 3-5Y Total Revenue Growth Rate | 75.1 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 62.61 | |||||
9-Day RSI | 59.86 | |||||
14-Day RSI | 59.39 | |||||
6-1 Month Momentum % | 8.98 | |||||
12-1 Month Momentum % | -33.27 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.98 | |||||
Quick Ratio | 4.83 | |||||
Cash Ratio | 4.6 | |||||
Days Inventory | 1045.21 | |||||
Days Sales Outstanding | 51.67 | |||||
Days Payable | 443.76 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | -2.68 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 68.39 | |||||
Operating Margin % | -972.56 | |||||
Net Margin % | -913.17 | |||||
FCF Margin % | -1106.04 | |||||
ROE % | -24.71 | |||||
ROA % | -18.92 | |||||
ROIC % | -68.92 | |||||
ROC (Joel Greenblatt) % | -77.14 | |||||
ROCE % | -20.18 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 130.76 | |||||
PB Ratio | 4.32 | |||||
Price-to-Tangible-Book | 4.33 | |||||
EV-to-EBIT | -13.1 | |||||
EV-to-EBITDA | -14.95 | |||||
EV-to-Revenue | 115.65 | |||||
EV-to-FCF | -10.52 | |||||
Price-to-Net-Current-Asset-Value | 7.03 | |||||
Price-to-Net-Cash | 8.1 | |||||
Earnings Yield (Greenblatt) % | -7.63 | |||||
FCF Yield % | -7.97 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Keymed Biosciences Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil HK$) | 88.368 | ||
EPS (TTM) (HK$) | -3.084 | ||
Beta | 0.63 | ||
Volatility % | 52.38 | ||
14-Day RSI | 59.39 | ||
14-Day ATR (HK$) | 3.199138 | ||
20-Day SMA (HK$) | 41.25 | ||
12-1 Month Momentum % | -33.27 | ||
52-Week Range (HK$) | 26.6 - 64.8 | ||
Shares Outstanding (Mil) | 277.39 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Keymed Biosciences Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Keymed Biosciences Inc Stock Events
Event | Date | Price(HK$) | ||
---|---|---|---|---|
No Event Data |
Keymed Biosciences Inc Frequently Asked Questions
What is Keymed Biosciences Inc(HKSE:02162)'s stock price today?
When is next earnings date of Keymed Biosciences Inc(HKSE:02162)?
Does Keymed Biosciences Inc(HKSE:02162) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |